{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:36:18Z","timestamp":1788978978679,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jocn.2025.111156","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T17:01:49Z","timestamp":1740675709000},"page":"111156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficacy and tolerability of valproate versus topiramate in migraine prevention, a randomized controlled multi-center trial"],"prefix":"10.1016","volume":"135","author":[{"given":"Mohamed G.","family":"Zeinhom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Fouad","family":"elsayed Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Youssif","family":"Omar Youssif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamed","family":"ali Daabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Almoataz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam Mohamed","family":"Refat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ahmed","family":"Mohamed Kamal Ebied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaa Mostafa","family":"Atiaa Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ismaiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Fathallah","family":"Mohamed Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa Ismail Ebrahim","family":"Elballat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Zaki","family":"Omar Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherihan Rezk","family":"ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2025.111156_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-024-02499-9","article-title":"The effect of lacosamide on calcitonin gene-related peptide serum level in episodic migraine patients: a randomized, controlled trial","author":"Elgamal","year":"2024","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"10.1016\/j.jocn.2025.111156_b0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1474-4422(08)70062-0","article-title":"Epidemiology and comorbidity of headache","volume":"7","author":"Jensen","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111156_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archneur.1995.00540270077022","article-title":"Migraine prophylaxis with divalproex","volume":"52","author":"Mathew","year":"1995","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2025.111156_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/00207454.2011.626908","article-title":"A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis","volume":"122","author":"Afshari","year":"2012","journal-title":"Int J Neurosci"},{"issue":"6","key":"10.1016\/j.jocn.2025.111156_b0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.wnf.0000192136.46145.44","article-title":"Efficacy of topiramate and valproate in chronic migraine","volume":"28","author":"Bartolini","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jocn.2025.111156_b0030","unstructured":"C. M.U., N. J., S. M., and Z. A., \u201cComparison between topiramate and Sodium valproate efficacy in the treatment of migraine,\u201d Pakistan J Med Heal Sci 2017; 11(3): 1005\u20137, [Online]. Available: http:\/\/www.embase.com\/search\/results?subaction=viewrecord&from=export&id=L619052321%0Ahttp:\/\/sfx.library.uu.nl\/utrecht?sid=EMBASE&issn=19967195&id=doi:&atitle=Comparison+between+topiramate+and+Sodium+valproate+efficacy+in+the+treatment+of+migraine&stitle=."},{"key":"10.1016\/j.jocn.2025.111156_b0035","doi-asserted-by":"crossref","unstructured":"\u201cThe International Classification of Headache Disorders, 3rd edition (beta version).,\u201d Cephalalgia 2013; 33(9): 629\u2013808. doi: 10.1177\/0333102413485658.","DOI":"10.1177\/0333102413485658"},{"issue":"9","key":"10.1016\/j.jocn.2025.111156_b0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The international classification of headache disorders, 3rd edition (beta version)","volume":"33","author":"Olesen","year":"2013","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.jocn.2025.111156_b0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0333102411417901","article-title":"Guidelines for controlled trials of drugs in migraine: third edition. a guide for investigators","volume":"32","author":"Tfelt-Hansen","year":"2012","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.jocn.2025.111156_b0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejpn.2005.05.004","article-title":"Sodium Valproate versus Propranolol in paediatric migraine prophylaxis","volume":"9","author":"Ashrafi","year":"2005","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"10.1016\/j.jocn.2025.111156_b0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1023\/A:1026167214355","article-title":"A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT)","volume":"12","author":"Bayliss","year":"2003","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jocn.2025.111156_b0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3988\/jcn.2008.4.4.158","article-title":"Headache Impact Test-6 (HIT-6) scores for migraine patients: their relation to disability as measured from a headache diary","volume":"4","author":"Shin","year":"2008","journal-title":"J Clin Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2025.111156_b0065","doi-asserted-by":"crossref","first-page":"29822","DOI":"10.1038\/s41598-024-76189-0","article-title":"A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis","volume":"14","author":"Zeinhom","year":"2024","journal-title":"Sci Rep"},{"issue":"0123456789","key":"10.1016\/j.jocn.2025.111156_b0070","article-title":"Ticagrelor versus clopidogrel in acute large \u2011 vessel ischemic stroke\u00a0: a randomized controlled single \u2011 blinded trial","volume":"450","author":"Zeinhom","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jocn.2025.111156_b0075","doi-asserted-by":"crossref","unstructured":"Rezk S, Nevine A, Nahas E, Fouad M, Khalil E, Elbassiouny A. \u201cORIGINAL RESEARCH ARTICLE TICA \u2011 CLOP STUDY\u00a0: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate \u2011 to \u2011 Severe Ischemic Stroke , a Randomized Controlled Multi \u2011 Center Trial,\u201d CNS Drugs, no. 0123456789, 2024, doi: 10.1007\/s40263-024-01127-7.","DOI":"10.1007\/s40263-024-01127-7"},{"issue":"11","key":"10.1016\/j.jocn.2025.111156_b0080","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1136\/gutjnl-2021-325210","article-title":"British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults","volume":"70","author":"Snook","year":"2021","journal-title":"Gut"},{"issue":"21","key":"10.1016\/j.jocn.2025.111156_b0085","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jamainternmed.2013.10391","article-title":"Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis","volume":"173","author":"Meissner","year":"2013","journal-title":"JAMA Intern Med,"},{"issue":"7","key":"10.1016\/j.jocn.2025.111156_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130733","article-title":"A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache","volume":"10","author":"Jackson","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jocn.2025.111156_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-023-01594-1","article-title":"The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis","volume":"24","author":"Lampl","year":"2023","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jocn.2025.111156_b0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s10194-018-0898-3","article-title":"Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European medicines agency and European headache federation","volume":"19","author":"Vatzaki","year":"2018","journal-title":"J Headache Pain"},{"issue":"7","key":"10.1016\/j.jocn.2025.111156_b0105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s40264-023-01314-3","article-title":"Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an interrupted time series study","volume":"46","author":"Abtahi","year":"2023","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.jocn.2025.111156_b0110","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1526-4610.2006.00413.x","article-title":"Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study","volume":"46","author":"Shaygannejad","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.jocn.2025.111156_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/njppp.2023.13.05235202225052022","article-title":"Open-label comparative study of the efficacy of sodium valproate and topiramate as prophylactic therapy for migraine in adults","volume":"13","author":"Gowlikar","year":"2023","journal-title":"Natl J Physiol Pharm Pharmacol"},{"issue":"5","key":"10.1016\/j.jocn.2025.111156_b0120","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bjp.0705850","article-title":"Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl-\/HCO3- exchange","volume":"142","author":"Leniger","year":"2004","journal-title":"Br J Pharmacol,"},{"key":"10.1016\/j.jocn.2025.111156_b0125","doi-asserted-by":"crossref","DOI":"10.4137\/JCNSD.S4365","article-title":"Topiramate: safety and efficacy of its use in the prevention and treatment of migraine","volume":"3","author":"Minton","year":"2011","journal-title":"J Cent Nerv Syst Dis"},{"issue":"2","key":"10.1016\/j.jocn.2025.111156_b0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1527-3458.2008.00041.x","article-title":"Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate","volume":"14","author":"Shank","year":"2008","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.jocn.2025.111156_b0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s10194-023-01671-5","article-title":"European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate","volume":"24","author":"Raffaelli","year":"2023","journal-title":"J Headache Pain"},{"issue":"10","key":"10.1016\/j.jocn.2025.111156_b0140","first-page":"5734","article-title":"The efficacy and safety of valproate medications for migraine in adults: a meta-analysis","volume":"24","author":"Cui","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.jocn.2025.111156_b0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0333102414534325","article-title":"Antiepileptics in migraine prophylaxis: an updated Cochrane review","volume":"35","author":"Mulleners","year":"2015","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.jocn.2025.111156_b0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/nedt.2006.2.3.261","article-title":"Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability","volume":"2","author":"D\u2019Amico","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jocn.2025.111156_b0155","first-page":"2013","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","volume":"6","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825001286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825001286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T14:40:34Z","timestamp":1755096034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825001286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"alternative-id":["S0967586825001286"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111156","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of valproate versus topiramate in migraine prevention, a randomized controlled multi-center trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111156"}}